Douglas Fair1, Luke Maese1,2, Yueh-Yun Chi3, Minjie Li4, Douglas S. Hawkins5, Rajkumar Venkatramani6, Erin Rudzinski7, David Parham8, Lisa Teot9, David Malkin10, Sharon E. Plon11,12, He Li12, Aniko Sabo12, Philip J. Lupo11*, Joshua D. Schiffman1,2*
1 Division of Hematology/Oncology, Department of Pediatrics, University of Utah, Primary Children’s Hospital, Huntsman Cancer Institute, Salt Lake City, Utah
2Family Cancer Assessment Clinic, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah
3Department of Pediatrics, University of Southern California, Los Angeles, California
4Statistics and Data Center, Children’s Oncology Group, Gainesville, Florida
5Seattle Children’s Hospital, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington
6Division of Hematology/Oncology, Department of Pediatrics, Texas Children’s Cancer Center, Texas Children’s Hospital, Baylor College of Medicine, Houston, Texas
7Department of Laboratories, Seattle Children’s Hospital, Seattle, Washington
8Department of Pathology and Laboratory Medicine, Children’s Hospital Los Angeles and Keck School of Medicine, University of Southern California, Los Angeles, California
9Department of Pathology, Boston Children’s Hospital, Boston, Massachusetts
10Division of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada
11Division of Hematology/Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas
12Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas
*Authors contributed equally
Corresponding author:
Douglas Fair, MD, MS, FAAP
Associate Professor, Division of Pediatric Hematology and Oncology, University of Utah
Primary Children’s Hospital | Huntsman Cancer Institute
100 N. Mario Capecchi Drive, Ste 4100
Salt Lake City, UT 84113
(801) 662-4700 (phone); (801) 662-4707 (Fax)
douglas.fair@hsc.utah.edu